p-kit mutation
@KitPSBL
Followers
85
Following
416
Statuses
53
RT @gvhd_hub: A new study published in @ASTCT_Journal found that lower-dose MMF improved relapse rates and PFS in patients receiving haploi…
0
4
0
RT @TalhaBadarMD: Finally out ➡️ A huge shout out for @MRLitzow @eaonc @MayoCancerCare Blinatumomab for MRD-Negative Acute Lymphoblastic L…
0
24
0
0
8
0
RT @fabianaperna: Thrilled to present the work of the Perna Lab at #Tandem24 @ASTCT Thank you Dr. Cathy Wu for the kind invitation 🙏🏻 htt…
0
5
0
RT @fabianaperna: Proud to share our work @CellRepMed describing a target discovery pipeline for immunotherapy of multiple myeloma. #Pern…
0
6
0
RT @TalhaBadarMD: Weekend review 📖 What is the right duration of VENETOCLAX with HMA for AML: 7 days vs 14 days vs 21 days or 28 days?…
0
46
0
RT @RahulBanerjeeMD: Congrats @GunjanLShah @GiraltSergio on tour de force review about literally EVERYTHING you could want to know about AS…
0
17
0
RT @TalhaBadarMD: #ASH23 The Benefit of Allogeneic Transplant in 1st CR in NPM1m AML with or without FLT3 ITD Is Restricted to Those Testin…
0
19
0
RT @ASTCT_Journal: A study found that #alloHCT is feasible after failure of chimeric antigen receptor T cell therapy (CAR-T) in patients wi…
0
3
0
RT @TalhaBadarMD: Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal https:/…
0
13
0
RT @TalhaBadarMD: Weekend review 📖 #ASH23, few selected #MDS abstracts to watch out at this year ASH meeting @ASH_hematology #mdssm 🧵 👇🏽…
0
15
0
RT @ASTCT_Journal: #alloHCT with younger matched unrelated donors (age ≤35 years) is associated with significantly decreased relapse risk &…
0
16
0
RT @Dr_KatLewis: Delighted to share our work now published on behalf of all co-authors. Our practice has changed- minimal use of HD-MTX i…
0
33
0
RT @MorphologyAmigo: #Amigotweetorials 1/9 Short Case 80♂️ Under Dermatologists for Pemphigus in a Medical Ward No Bleeding History Befor…
0
13
0
RT @WilliamAird4: 1/9 EXAMPLE OF Hb-Hct DISCORDANCE Take a look at the values in the graphic. Without looking ahead in the thread, can yo…
0
329
0
RT @NicoGagelmann: 🎉Finally out🎉 We propose molecular monitoring + donor lymphocyte infusion as standard of care for relapsed myelofibrosi…
0
19
0
RT @NicoGagelmann: 😱Complications in hematology😱 Human herpes virus 6 (HHV-6) infection A short🧵 #MedTwitter 1/19
0
129
0